Nasdaq

WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM

Announces commercial focus on BioOxiTM bio-oxidation platform as part of targeted alignment on nearer-term and larger revenue opportunities Reduces number of board members as part of geographic ...
Seeking Alpha

WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONE

Solid execution on development phases leads to execution of agreement; illustrates company progress against targeted milestones anticipated for 2023 to expand company growth Willow's unique ...
Seeking Alpha

WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.

The agreement with Kalsec anticipates milestone payments for finalizing research and development work and a royalty stream for Willow upon commercialization SUNNYVALE, Calif., Sept. 5, 2024 /CNW/ - ...
Nasdaq

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

VANCOUVER, BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed the first commercial scale ...
Business Insider

Willow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG Committee

VANCOUVER, BC, July 20, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF), a leading biotechnology company that manufactures ultra-pure, sustainably ...
Commercial Observer

Willow Names Microsoft Executive Bert Van Hoof President and COO

Digital twinning proptech firm Willow announced Wednesday that Bert Van Hoof, former partner at Microsoft Azure IoT, has been named Willow’s president and chief operating officer. In his new role, Van ...